The increasing elderly population in Japan presents multifaceted challenges, intricately interwoven with advancements in genetic research and the complexities of the social welfare system. Genetic information, while offering potential breakthroughs in understanding age-related diseases and tailoring preventative measures, also raises ethical dilemmas concerning privacy and potential discrimination. Consider the scenario of an elderly individual requiring long-term care. The costs associated with such care can be exorbitant, often placing a significant strain on families and pushing some towards dependence on the national social welfare system, known as 'seikatsu hogo'. Eligibility for seikatsu hogo is determined by a complex assessment of income, assets, and health conditions. However, the integration of genetic predispositions to specific illnesses into this assessment remains a largely unexplored area. Should an individual with a genetic predisposition to Alzheimer's, for example, receive preferential consideration in seikatsu hogo applications? This question touches upon fundamental issues of fairness, equity, and resource allocation. The use of genetic information in determining eligibility for social support could potentially lead to discrimination against those deemed 'genetically predisposed' to costly conditions. Simultaneously, ignoring this information might mean overlooking individuals who urgently require support due to their genetic vulnerability. Furthermore, the privacy concerns surrounding genetic data and the potential for misuse add another layer of ethical complexity. The Japanese government grapples with the need to balance compassion, fiscal responsibility, and ethical considerations as it navigates the future of elderly care and the role of genetic information within this landscape. The debate highlights the intricate connections between scientific advancements, societal welfare, and the ongoing evolution of social policy in an aging society.
1. According to the passage, what is one of the major challenges related to the increasing elderly population in Japan?
2. What ethical dilemma is raised regarding the use of genetic information in the context of elderly care?
3. What is 'seikatsu hogo' as mentioned in the passage?
4. What is the main point of contention regarding the use of genetic information in determining eligibility for seikatsu hogo?